EUR/USD
1.15248
-0.732%
Gold
4318.68
-3.497%
Oil
88.549
-2.697%
USD/JPY
160.177
0.098%
GBP/USD
1.33372
-0.643%
GBP/JPY
213.636
-0.547%
Real-time News
According to the Financial Times, OpenAI is preparing for the biggest overhaul of ChatGPT since its launch. The company plans to transform ChatGPT into a "super app" that combines coding tools and AI agents, and add products that executives believe will generate more revenue.June 7th - Yesterday (June 6th), the worlds first prefabricated computing center base was officially put into use in Qingdao, Shandong. Compared to traditional computing centers, it saves nearly 70% of the construction time, providing a more efficient and lower-carbon solution for current computing infrastructure construction. Simply put, the computing center base is the energy hub and power fortress of the computing center, also known as the "heart" of the center, providing a continuous and stable power supply. The stability of the bases power supply and its energy efficiency directly affect the overall working capacity of the computing center.June 7th - The price of household liquefied petroleum gas (LPG) in Delhi, India, has increased by 29 rupees per can (approximately US$0.3054). According to the website of Indian Oil Corporation, Indias largest state-owned refiner and fuel retailer, the company has raised the price of a 14.2 kg can of household LPG in Delhi from 913 rupees to 942 rupees, effective June 7th. Indias three major state-owned fuel retailers typically adjust fuel retail prices in tandem.On June 7th, AstraZeneca CEO Robert Soriot warned that, given the terms of its agreement with the Trump administration to reduce drug costs for US patients, the pharmaceutical giant may be forced to suspend the launch of new drugs in the UK and Europe if it cannot secure higher drug prices. Soriot stated that European countries must increase investment in innovative drugs, otherwise the Anglo-Swiss joint venture will have no choice but to focus almost entirely on the US market, as nearly half of its revenue comes from the US.On June 7th, Eli Lilly (LLY.N) announced the results of a trial of its next-generation weight-loss drug, Retatrutide, to medical experts. The results showed that in addition to promoting weight loss and relieving knee pain, the drug can also reduce the severity of sleep apnea. In a phase 3 clinical trial, Eli Lilly found that once-weekly injections of Retatrutide reduced symptoms of moderate to severe obstructive sleep apnea by 60.6% in obese adult patients. In the same trial, Eli Lilly also found that the drug reduced pain in patients with knee osteoarthritis by up to 73.1%.
